文献速递免疫规划传染病防控与疫情报告

西班牙北部2018-2019季节当前及既往流感疫苗接种的效果

Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019.
PubMed 文献 · Vaccine · 2020-01-22

在西班牙纳瓦拉,对2018-2019季节流感样病例就医或住院患者检测流感,采用检测阴性设计评估当前和既往三个季节接种灭活流感疫苗的效果。针对A(H1N1)pdm09,当前季节接种疫苗效果为57%(95%CI:40%,70%),仅既往季节接种为48%(95%CI:14%,68%);针对A(H3N2)分别为12%(95%CI:-23%,37%)和27%(95%CI:-22%,56%)。

要点

  • 当前季节接种疫苗对A(H1N1)pdm09效果57%(95%CI:40%,70%),对A(H3N2)效果12%(95%CI:-23%,37%)。
  • 仅既往季节接种对A(H1N1)pdm09效果48%(95%CI:14%,68%),对A(H3N2)效果27%(95%CI:-22%,56%)。
  • 接种含A/Michigan/45/2015和A/California/07/2009两株疫苗者对A(H1N1)pdm09保护68%(95%CI:53%,77%),高于仅接种A/Michigan/45/2015者29%(p=0.020)或仅接种A/California/07/2009者34%(p=0.005)。

核心结论

  • 结果表明2018-2019季节流感疫苗对A(H1N1)pdm09具有中等效果,对A(H3N2)流感效果低。
  • 既往季节接种疫苗维持了明显的保护效果。
  • 既往疫苗所含毒株与当前疫苗毒株效果相当,且两者对A(H1N1)pdm09的效果相加。

研究设计与样本

  • 研究在西班牙纳瓦拉进行,纳入由哨点全科医生诊治或住院的流感样病例患者并检测流感。
  • 从疫苗接种登记处获取当前及既往三个季节的接种状态。
  • 采用检测阴性设计估计疫苗效果。
  • 分析共纳入381例A(H1N1)pdm09病例、341例A(H3N2)病例和1222例对照。

主要发现

  • 与当前及既往三个季节均未接种者相比,当前季节接种(无论既往剂次)对A(H1N1)pdm09的疫苗效果为57%(95%CI:40%,70%),仅既往季节接种为48%(95%CI:14%,68%)。
  • 与当前及既往三个季节均未接种者相比,当前季节接种对A(H3N2)的疫苗效果为12%(95%CI:-23%,37%),仅既往季节接种为27%(95%CI:-22%,56%)。
  • 接种含A/Michigan/45/2015和A/California/07/2009两株疫苗者对A(H1N1)pdm09保护为68%(95%CI:53%,77%),高于仅接种A/Michigan/45/2015者29%(p=0.020)或仅接种A/California/07/2009者34%(p=0.005)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The population targeted for influenza vaccination can be repeatedly vaccinated over successive seasons, and vaccines received in previous seasons may retain preventive effect. This study aims to estimate the effectiveness of inactivated influenza vaccines received in the current and prior seasons in the 2018-2019 season. METHODS: Influenza-like illness patients attended by sentinel general practitioners or admitted to hospitals in Navarre, Spain, were tested for influenza. Vaccination status in the current and three prior seasons was obtained from the vaccination registry. The test-negative design was used to estimate the vaccine effectiveness. RESULTS: A total of 381 influenza A(H1N1)pdm09 cases, 341 A(H3N2) cases and 1222 controls were analysed. As compared to individuals unvaccinated in the current and three prior seasons, the influenza vaccine effectiveness against A(H1N1)pdm09 was 57% (95% confidence interval [CI]: 40%, 70%) for current season vaccination regardless of prior doses and 48% (95%CI: 14%, 68%) for vaccination in prior seasons but not in the current season. These estimates were 12% (95%CI: -23%, 37%) and 27% (95%CI: -22%, 56%), respectively, against influenza A(H3N2). Individuals vaccinated with the two A(H1N1)pdm09 strains in influenza vaccines since 2009, A/Michigan/45/2015 and A/California/07/2009, had higher protection (68%; 95%CI: 53%, 77%) than those vaccinated with A/Michigan/45/2015 only (29%, p = 0.020) or with A/California/07/2009 only (34%, p = 0.005). CONCLUSION: These results suggest moderate effectiveness of influenza vaccination against A(H1N1)pdm09 and low effectiveness against A(H3N2) influenza in the 2018-2019 season. Vaccination in prior seasons maintained a notable protective effect. Strains included in previous vaccines were as effective as the current vaccine strain, and both added their effects against influenza A(H1N1)pdm09.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Castilla J, Portillo ME, Casado I, et al. Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019. Vaccine. 2020. PMID: 31982263. doi:10.1016/j.vaccine.2020.01.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。